Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial.
about
Efficacy and safety of ablation for patients with non-paroxysmal atrial fibrillationPrediction of atrial fibrillation development and progression: Current perspectivesSurgical perspectives in the management of atrial fibrillationAtrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectivesCatheter Ablation for Long-Standing Persistent Atrial FibrillationAblating Atrial Fibrillation: Customizing Lesion Sets Guided by Rotor MappingCatheter Ablation of Paroxysmal Atrial Fibrillation: Have We Achieved Cure with Pulmonary Vein Isolation?Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablationMechanisms of atrial fibrillation: rotors, ionic determinants, and excitation frequencyHighlights of the year in JACC 2012The role of rotors in atrial fibrillationRotors as drivers of atrial fibrillation and targets for ablationNovel Radiofrequency Ablation Strategies for Terminating Atrial Fibrillation in the Left Atrium: A Simulation Study.Localized rotors and focal impulse sources within the left atrium in human atrial fibrillation: A phase analysis of contact basket catheter electrogramsElectrophysiological Rotor Ablation in In-Silico Modeling of Atrial Fibrillation: Comparisons with Dominant Frequency, Shannon Entropy, and Phase SingularityFrontiers in Noninvasive Cardiac Mapping2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.QUest for the Arrhythmogenic Substrate of Atrial fibRillation in Patients Undergoing Cardiac Surgery (QUASAR Study): Rationale and DesignModelling the heart as a communication system.Modifying Ventricular Fibrillation by Targeted Rotor Substrate Ablation: Proof-of-Concept from Experimental Studies to Clinical VF.Effects of Heterogeneous Diffuse Fibrosis on Arrhythmia Dynamics and Mechanism.Electrophysiological Perspectives on Hybrid Ablation of Atrial Fibrillation.Recurrent Atrial Fibrillation After Catheter Ablation: Considerations For Repeat Ablation And Strategies To Optimize Success.Mapping Atrial Fibrillation: 2015 UpdateSurgical Ablation of Atrial Fibrillation: is Electrical Isolation of the Pulmonary Veins a Must?Advanced Mapping Systems To Guide Atrial Fibrillation Ablation: Electrical Information That MattersHybrid approaches in atrial fibrillation ablation: why, where and who?Adjunct ablation strategies for persistent atrial fibrillation-beyond pulmonary vein isolationElimination Of Triggers Without An Additional Substrate Modification Is Not Sufficient In Patients With Persistent Atrial FibrillationElectroanatomical mapping of atrial fibrillation: Review of the current techniques and advancesIs pulmonary vein isolation still the cornerstone in atrial fibrillation ablation?Repetitive atrial activation during ongoing atrial fibrillation-comparison using different mapping algorithms: preliminary findings.Spatial Relationship of Focal Impulses, Rotors and Low Voltage Zones in Patients With Persistent Atrial Fibrillation.Better Lesion Creation And Assessment During Catheter Ablation.Acute termination of human atrial fibrillation by identification and catheter ablation of localized rotors and sources: first multicenter experience of focal impulse and rotor modulation (FIRM) ablation.Panoramic electrophysiological mapping but not electrogram morphology identifies stable sources for human atrial fibrillation: stable atrial fibrillation rotors and focal sources relate poorly to fractionated electrograms.Electrogram morphology recurrence patterns during atrial fibrillation.Basket-Type Catheters: Diagnostic Pitfalls Caused by Deformation and Limited Coverage.Low-Cost Optical Mapping Systems for Panoramic Imaging of Complex Arrhythmias and Drug-Action in Translational Heart ModelsSpatial Resolution Requirements for Accurate Identification of Drivers of Atrial Fibrillation.
P2860
Q24186195-D177D87F-B05B-498D-912A-ECED496FB356Q26750083-BB15FC96-6674-40EA-A55D-1473F8BA65D7Q26769985-A773350C-2DF6-4F48-8126-280920962A02Q26778659-7B040849-413B-4BB0-92E4-A92CF7E927CEQ26797441-719DC69F-F8CF-4AF8-898E-5B50E7684828Q26797445-197B6474-87F5-49D2-AD9B-7256FF11D27FQ26797446-C5A681FD-2E88-4450-80FC-565CAFE4A1CFQ26864767-D2ED0725-E592-4E7D-9A01-D6633014F40CQ26865072-D6587578-A942-45F1-B887-D6C4B31EBDF1Q26865608-E12C74FF-C01E-4812-BCCE-DD129B252F2EQ27002365-8EDC373A-88EF-4E94-BE34-AAE3C5ED8867Q27006026-13594F51-CE39-4D61-8F05-8D5DA75CC306Q27307882-B245DD71-7898-4DF4-971A-F7700EEB8816Q27309166-F676F340-1939-4DC9-AD4D-2549D98422C3Q27320801-74C75144-6F20-480F-9594-A18DB7060F6FQ27324329-3FB47ECF-4833-47CA-904C-E0B853CAE5BCQ27341873-38249015-1A79-46A6-9207-86C5F42A297DQ27343062-D69FD6BE-DCDE-46B2-83E5-0F41F101292CQ27345274-230E5BB7-B4A3-42DC-92B8-0D2EFF340B05Q27348940-D3F50734-FCCD-4BB1-8D1A-0B4E81F4DFF2Q27349919-7F1A2783-17FC-44AD-B545-87E023BE7C51Q28073160-F97DCBFF-370A-4D38-B643-8589D943F768Q28073650-BBB7962C-62C7-4DD9-88BC-B9D3225B63F3Q28075512-F31AE951-B49F-4A51-A604-6E97D7A6310BQ28077137-B5FCD423-0859-4192-8CEC-234318E16B5AQ28079146-E695C62E-0A0B-4F5F-948F-8946855F47BDQ28080696-077B4608-F497-4F10-BACD-E3452225126BQ28081592-DABD34E5-A35F-40A3-838C-45228DA2737BQ28084012-FDE47664-BC2D-4C2D-A560-CCB049E2B17FQ28084974-CF3E2CE5-5AC0-4964-AC34-BE7208C63976Q28085297-7DDAA2F2-4F5A-4E54-A656-D1823892B7F4Q30313291-04C2173D-E9B8-446B-A98E-6E498104A58BQ30315833-4C99E852-D3A8-4263-BB3F-679687613ED0Q30368110-0D5BF38E-3219-4F93-AC04-3A6B236AC25BQ30530209-EED95BF6-602F-4672-AB1F-267070620DC7Q30543138-552E38AC-B5C9-4039-8235-F0BA54015FC2Q30604297-5018C7DD-F109-44EE-922E-4E9D0B286AF6Q30833115-EBFFBBC1-3043-46D5-9D29-FAF64DEB6495Q30839986-0DF688E6-A3EA-48F1-9FAA-CE7D739542ADQ30851198-AFEE3915-DDB2-4F4B-9A71-512A51E3B1BB
P2860
Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Treatment of atrial fibrillati ...... se and Rotor Modulation) trial
@nl
Treatment of atrial fibrillati ...... e and Rotor Modulation) trial.
@ast
Treatment of atrial fibrillati ...... e and Rotor Modulation) trial.
@en
type
label
Treatment of atrial fibrillati ...... se and Rotor Modulation) trial
@nl
Treatment of atrial fibrillati ...... e and Rotor Modulation) trial.
@ast
Treatment of atrial fibrillati ...... e and Rotor Modulation) trial.
@en
prefLabel
Treatment of atrial fibrillati ...... se and Rotor Modulation) trial
@nl
Treatment of atrial fibrillati ...... e and Rotor Modulation) trial.
@ast
Treatment of atrial fibrillati ...... e and Rotor Modulation) trial.
@en
P2093
P2860
P3181
P1476
Treatment of atrial fibrillati ...... e and Rotor Modulation) trial.
@en
P2093
David E Krummen
John M Miller
Kalyanam Shivkumar
Paul Clopton
Sanjiv M Narayan
P2860
P304
P3181
P356
10.1016/J.JACC.2012.05.022
P407
P577
2012-07-18T00:00:00Z